These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23347437)

  • 1. Survey of non-B, non-C liver cirrhosis in Japan.
    Suzuki Y; Ohtake T; Nishiguchi S; Hashimoto E; Aoyagi Y; Onji M; Kohgo Y;
    Hepatol Res; 2013 Oct; 43(10):1020-31. PubMed ID: 23347437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
    Nagaoki Y; Hyogo H; Ando Y; Kosaka Y; Uchikawa S; Nishida Y; Teraoka Y; Morio K; Fujino H; Ono A; Nakahara T; Murakami E; Yamauchi M; Okamoto W; Kawaoka T; Tsuge M; Hiramatsu A; Miki D; Imamura M; Takahashi S; Chayama K; Aikata H
    BMC Gastroenterol; 2021 Jul; 21(1):306. PubMed ID: 34332532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology of liver cirrhosis in Japan: a nationwide survey.
    Michitaka K; Nishiguchi S; Aoyagi Y; Hiasa Y; Tokumoto Y; Onji M;
    J Gastroenterol; 2010; 45(1):86-94. PubMed ID: 19789837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.
    Enomoto H; Ueno Y; Hiasa Y; Nishikawa H; Hige S; Takikawa Y; Taniai M; Ishikawa T; Yasui K; Takaki A; Takaguchi K; Ido A; Kurosaki M; Kanto T; Nishiguchi S;
    J Gastroenterol; 2021 Feb; 56(2):158-167. PubMed ID: 33219410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trend of clinical features in patients with hepatocellular carcinoma.
    Nagaoki Y; Hyogo H; Aikata H; Tanaka M; Naeshiro N; Nakahara T; Honda Y; Miyaki D; Kawaoka T; Takaki S; Hiramatsu A; Waki K; Imamura M; Kawakami Y; Takahashi S; Chayama K
    Hepatol Res; 2012 Apr; 42(4):368-75. PubMed ID: 22151896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea.
    Kim J; Kang W; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Korean J Intern Med; 2020 Jan; 35(1):65-78. PubMed ID: 31189301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.
    Oda K; Uto H; Mawatari S; Ido A
    Clin J Gastroenterol; 2015 Feb; 8(1):1-9. PubMed ID: 25575848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease.
    Kodama K; Tokushige K; Hashimoto E; Taniai M; Shiratori K
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E247-52. PubMed ID: 23320802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics of hepatitis B surface antigen-negative and hepatitis C antibody-negative hepatocellular carcinoma.
    Iida H; Aihara T; Ikuta S; Yamanaka N
    Oncol Lett; 2015 Oct; 10(4):2233-2238. PubMed ID: 26622825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
    Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.
    Enomoto H; Ueno Y; Hiasa Y; Nishikawa H; Hige S; Takikawa Y; Taniai M; Ishikawa T; Yasui K; Takaki A; Takaguchi K; Ido A; Kurosaki M; Kanto T; Nishiguchi S;
    J Gastroenterol; 2020 Mar; 55(3):353-362. PubMed ID: 31768801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021.
    Enomoto H; Akuta N; Hikita H; Suda G; Inoue J; Tamaki N; Ito K; Akahane T; Kawaoka T; Morishita A; Ogawa E; Tateishi R; Yoshiji H
    Hepatol Res; 2024 Aug; 54(8):763-772. PubMed ID: 38638067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study.
    Kim SK; Marusawa H; Eso Y; Nishikawa H; Ueda Y; Kita R; Kimura T; Chiba T; Osaki Y; Kudo M
    Digestion; 2011; 84 Suppl 1():43-9. PubMed ID: 22156485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.
    Hashimoto E; Taniai M; Kaneda H; Tokushige K; Hasegawa K; Okuda H; Shiratori K; Takasaki K
    Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):164S-168S. PubMed ID: 15318106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
    Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
    Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-B, non-C hepatocellular carcinoma (Review).
    Nishikawa H; Osaki Y
    Int J Oncol; 2013 Nov; 43(5):1333-42. PubMed ID: 23969900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
    Doycheva I; Zhang T; Amjad W; Thuluvath PJ
    J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.